ARS Pharmaceuticals, Inc. (SPRY)
13.06
+2.11
(+19.27%)
USD |
NASDAQ |
Jan 09, 16:00
13.03
-0.03
(-0.23%)
After-Hours: 20:00
ARS Pharmaceuticals EPS Diluted (Quarterly): -0.5177 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lipocine, Inc. | -0.5887 |
| Inspire Medical Systems, Inc. | 0.3355 |
| Vivos Therapeutics, Inc. | -0.4925 |
| MBX Biosciences, Inc. | -0.6321 |
| CapsoVision, Inc. | -0.1693 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.15M |
| Revenue (Quarterly) | 32.50M |
| Total Expenses (Quarterly) | 83.65M |
| Enterprise Value | 1.101B |
| Gross Profit Margin (Quarterly) | 74.80% |
| Profit Margin (Quarterly) | -157.4% |
| Earnings Yield | -6.20% |
| Normalized Earnings Yield | -6.204 |